SHC — Sotera Health Co Income Statement
0.000.00%
Last trade - 00:00- $4.25bn
- $6.15bn
- $1.16bn
Annual income statement for Sotera Health Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 931 | 1,004 | 1,049 | 1,100 | 1,164 |
| Cost of Revenue | |||||
| Gross Profit | 519 | 557 | 577 | 602 | 646 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 695 | 1,173 | 808 | 827 | 868 |
| Operating Profit | 236 | -169 | 242 | 273 | 296 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 176 | -243 | 106 | 114 | 148 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 117 | -234 | 51.4 | 44.4 | 77.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 117 | -234 | 51.4 | 44.4 | 77.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 115 | -234 | 51.1 | 44.3 | 77.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.566 | 0.324 | 0.377 | 0.302 | 0.495 |